Is the Way Up the Way Forward? Radiotherapy Dose Escalation for Non-small Cell Lung Cancer
Targeting mTOR Signaling for Lung Cancer Therapy
Conformal High Dose External Radiation Therapy, 80.5 Gy, Alone for Medically Inoperable Non-small Cell Lung Cancer: A Retrospective Analysis
Significance of the Number of Positive Lymph Nodes in Resected Non-small Cell Lung Cancer
Bortezomib Plus Docetaxel in Advanced Non-small Cell Lung Cancer and Other Solid Tumors: A Phase I California Cancer Consortium Trial
Phase II Trial of Gemcitabine-Carboplatin-Paclitaxel as Neoadjuvant Chemotherapy for Operable Non-small Cell Lung Cancer
A Phase II Randomized Study of Paclitaxel Plus Carboplatin or Cisplatin against Chemo-Naive Inoperable Non-small Cell Lung Cancer in the Elderly
Association between Anemia Arising during Therapy and Outcomes of Chemoradiation for Limited Small-cell Lung Cancer
Prognostic Value of Fluorodeoxyglucose Positron Emission Tomography in Non-small Cell Lung Cancer: A Review
The ACIN1 Gene is Hypermethylated in Early Stage Lung Adenocarcinoma
Massive Adrenal Metastasis
Evolving Aspects of Mesothelioma Carcinogenesis: SV40 and Genetic Predisposition
Soluble Mesothelin Related Protein in Mesothelioma
Macroscopic Complete Resection: The Goal of Primary Surgery in Multimodality Therapy for Pleural Mesothelioma
Newer Issues in Mesothelioma Chemotherapy
Adjuvant Chemotherapy for Resected Non-small Cell Lung Cancer
Atypical Primary Epithelioid Hemangioendothelioma of the Heart
Meeting Summary of the 12th International Conference on Screening for Lung Cancer: Nara, Japan, April 2005